Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) reports the results of the Annual General Meeting (AGM) held on May 23, 2007. The document details shareholder voting outcomes for 15 resolutions, including the adoption of financial statements, board elections, and corporate governance matters.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting statistics rather than financial performance metrics.
Material Changes Versus Prior Period
Comparative data is provided regarding shareholder participation and capital structure between the 2007 and 2006 AGMs:
- Issued Share Capital: Decreased from 5,820,406,967 shares in 2006 to 5,725,158,425 shares in 2007 (excluding Treasury Shares).
- Shareholder Participation: The percentage of issued share capital represented by votes cast and withheld increased from 71.77% in 2006 to 73.68% in 2007.
- Shareholder Population: Decreased from 192,331 in 2006 to 180,486 in 2007.
- Proxy Lodgement: The percentage of shareholders lodging proxies decreased slightly from 8.27% to 7.95%.
Guidance, Outlook, and Voting Results
All 15 resolutions presented at the AGM were passed by shareholders. Key voting outcomes include:
- Financial Statements: Adopted with 97.25% of votes cast in favor.
- Remuneration Report: Approved with 92.55% of votes cast in favor.
- Board Elections: All director elections and re-elections passed with support ranging from 95.69% to 99.58%.
- Share Buyback Authority: Authority for the company to purchase its own shares was approved with 99.69% support.
- Special Resolutions: Resolutions requiring a 75% majority (including the disapplication of pre-emption rights and amendment to Articles of Association) were successfully passed.
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies.
Important Facts for Investor Verification
- Verify the reduction in issued share capital between 2006 and 2007 to confirm the extent of share buybacks or other capital actions.
- Confirm the specific financial results referenced in the "Adoption of Financial Statements" resolution by reviewing the company's full annual report.
- Review the details of the "Remuneration Report" approval, noting it received the lowest approval percentage (92.55%) among the major resolutions.
- Check the company website (www.gsk.com) for the detailed breakdown of the financial statements and remuneration policies referenced in the voting results.